EUVIMEDEUVIMED entdecken
Open Access

Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US

Kristin R V Harrington, Christina Chandra, Daniel I Alohan, Diego Cruz, Henry N Young, Aaron J Siegler, Natalie D Crawford

JAMA Network Open · 2023

DOI: 10.1001/jamanetworkopen.2023.26028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von Kristin R V Harrington und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. Hauptthemen laut MEDLINE: HIV Infections, Pharmacies, Pharmaceutical Services, Pharmacy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Daily preexposure prophylaxis (PrEP) use can prevent up to 99% of HIV infections; however, PrEP uptake is low due to poor access to PrEP-prescribing locations for populations at increased risk for HIV, especially in the southeastern US. Pharmacies are a feasible option to increase PrEP access, but little is known about how they could complement current PrEP-prescribing locations.

Objective

To examine geographic distributions of current PrEP-prescribing locations compared with pharmacies and the facility to need ratios (PFNRs) according to HIV risk in the Southeast and describe the potential reach of pharmacies to expand PrEP access. Design, Setting, and Participants Data for this cross-sectional study of PrEP-prescribing locations and pharmacies were compiled from January 1 to December 31, 2021. States or specific counties in the Southeast included in this study were jurisdictions identified as high-priority areas for the Ending the HIV Epidemic in the US (EHE) initiative. Exposure Expansion of HIV prevention services to pharmacies. Main Outcomes and Measures Choropleth maps of 5-year HIV risk per 100 000 persons were developed for EHE jurisdictions in the southeastern US. PrEP-prescribing locations (obtained from a national database of PrEP prescribers) and pharmacies (obtained from state pharmacy boards) were overlayed on HIV risk maps. The PFNRs by state were calculated as number of facilities (PrEP-prescribing locations or pharmacies) divided by 5-year HIV risk per 100 000 persons. Lower PFNRs indicated lower geographic availability of locations to meet the needs of the population at risk for HIV. The PFNRs for current PrEP-prescribing locations vs pharmacies were compared.

Results

Among the 2 southeastern states and 13 counties in 4 southeastern states included, PrEP-prescribing locations were unequally distributed across EHE areas, with substantially fewer in areas at high risk for HIV. Pharmacies were evenly dispersed across areas regardless of HIV risk. The mean PFNR across all states for current PrEP-prescribing locations was 0.008 (median, 0.000 [IQR, 0.000-0.003]); for pharmacies, it was 0.7 (median, 0.3 [IQR, 0.01-0.1]). The PFNRs were at least 20.3 times higher for pharmacies compared with PrEP-prescribing locations. States with the greatest potential increase in PFNRs with expansion to pharmacies included Kentucky, South Carolina, and Tennessee. Conclusions and Relevance The findings of this cross-sectional study suggest that expanding HIV prevention services to pharmacies in EHE areas in the Southeast could significantly increase capacity to reach individuals at increased risk of HIV transmission. Legislation aimed at allowing pharmacists to prescribe PrEP and provide HIV prevention services may be an important next step in ending the HIV epidemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPharmaciesPharmaceutical ServicesPharmacyHumansCross-Sectional Studies

Autor:innen und Institutionen

  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Department of Medicine, Emory University School of Medicine, Emory University, Atlanta, Georgia.
  • Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens.

Förderung

  • NIAID NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Harrington, K. R. V., Chandra, C., Alohan, D. I., Cruz, D., Young, H. N., Siegler, A. J., & Crawford, N. D. (2023). Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.26028

Vancouver

Harrington KRV, Chandra C, Alohan DI, Cruz D, Young HN, Siegler AJ, et al. Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.26028

BibTeX
@article{Harrington2023,
  author = {Harrington, Kristin R V and Chandra, Christina and Alohan, Daniel I and Cruz, Diego and Young, Henry N and Siegler, Aaron J and Crawford, Natalie D},
  title = {Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US},
  journal = {JAMA Network Open},
  year = {2023},
  doi = {10.1001/jamanetworkopen.2023.26028}
}
Kostenlos starten →